Supernus Pharmaceuticals reported $16.67M in Pre-Tax Profit for its fiscal quarter ending in June of 2025.


Pre Tax Profit Change Date
Abbott USD 2.15B 372M Jun/2025
ANI Pharmaceuticals USD 10.52M 9.47M Jun/2025
Aurora Cannabis CAD -19380000 51.45M Jun/2025
Bristol-Myers Squibb USD 1.77B 1.2B Jun/2025
Canopy Growth CAD -41240000 80.34M Jun/2025
Corcept Therapeutics USD 31.69M 22.07M Jun/2025
Eisai JPY 22.4B 22.43B Jun/2025
Eli Lilly USD 6.78B 3.32B Jun/2025
Novo Nordisk 33.8B 3.23B Jun/2025
Pacira USD -1927000 10.63M Jun/2025
Perrigo USD 3.2M 5.1M Jun/2025
Pfizer USD 3.04B 259M Jun/2025
Supernus Pharmaceuticals USD 16.67M 22.5M Jun/2025
United Therapeutics USD 408.4M 15.1M Jun/2025
Xeris Pharmaceuticals USD -1930000 3.18M Jun/2025